Question 1

Has David Robaczewski, MD received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $57,606 in general payments to David Robaczewski, MD across 97 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean David Robaczewski, MD did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about David Robaczewski, MD come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
Livanova USA, Inc.	34	$30,140
Atricure, Inc.	42	$26,835
Abiomed	3	$181
Getinge USA Sales, LLC	4	$132
Edwards Lifesciences	2	$106
Abbott	5	$94
Sanara Medtech Inc.	4	$72
Medtronic	2	$35
Smith+Nephew	1	$11

David Robaczewski, MD

Payments from drug & device makers

Who reported the general payments

What the payments were tied to

How this compares

Medicare billing

Other thoracic surgery (cardiothoracic vascular surgery) in Pensacola